Australia's oldest melanoma survivor steps up to save lives on his 105th birthday
11 March 2021
He beat melanoma at 101 thanks to breakthrough immunotherapy treatment, and four years later World War II veteran Bert Collins is taking steps to help save others from the deadly disease.
Bert today celebrated his 105th birthday at his Bankstown home, dedicating the milestone to urging his fellow Australians to join him in helping raise $500,000 for research into new life-saving melanoma treatments.
‘I figured something had to get me in the end, and so no doubt melanoma would be it,’ Bert said. ‘But research saved my life, and so I am delighted to be stepping up at 105 to help save others.’
Bert is taking part in this year’s Melanoma March campaign, where Aussies are urged to leave their footprint on melanoma by buying a $30 digital footprint, personalising it with a message of support, and sharing it to socials. Melanoma Institute Australia wants to cover Australia in digital footprints by the end of the month.
With no social accounts to share his personalised footprint, Bert is going ‘old school’ and will be leaving real footprints in his backyard in March. He’s not sure how many steps he’ll take, but the one-time ballroom dancer and avid gardener is confident he will get outside every day.
‘This is my way of giving back, and my 105th birthday wish is for other Australians to help me by buying their own digital footprint and personalising it with a message of support,’ Bert said.
Bert’s melanoma had already spread to his brain, lungs and liver when he was diagnosed with the disease in 2017. Deemed by his local oncologist to be too frail for any treatment, he was referred to Melanoma Institute Australia where he met oncologist Associate Professor Alex Menzies who is 65 years his junior.
‘Although Bert’s melanoma was advanced, he was otherwise well and was much fitter than most men 20 years younger,’ Associate Professor Menzies said. ‘So we immediately started a short course of treatment hoping for the best. I’d never had a patient as senior as Bert, so we didn’t know exactly how his body would respond,’ he said.
After just four doses of immunotherapy, which harnesses the body’s own immune system to rally and fight the cancer cells, Bert’s tumours had disappeared and he had no toxicity from treatment. He ceased treatment at that point and four years later remains disease free, making him Australia’s oldest melanoma survivor.
Associate Professor Menzies says ‘Bert has my number’ in case he ever needs it.
Bert knows he was one of the lucky ones. Some 50% of advanced melanoma patients don’t respond to the new treatments that saved his life, with an estimated 1300 Aussies expected to die from the disease this year. Australia has the highest melanoma rates in the world with one person diagnosed with the disease every 30 minutes.
‘Thanks to ongoing research, we have come so far in finding new and more effective treatments for melanoma but we still have a long way to go if we are to save more lives,’ Associate Professor Menzies said. ‘Bert is amazing, he is a true Aussie legend who is continuing to live a life of service to help others, and I hope all of Australia gets behind him.’
To buy join Bert in buying a digital footprint and watch Australia be progressively covered in footprints, go to www.melanomamarch.org.au
MEDIA - For more information, please contact:
Jennifer Durante |Melanoma Institute Australia | 0412 798 990 | firstname.lastname@example.org
Former Executive Director of Melanoma Institute Australia Professor John Thompson awarded the prestigious 2018 RPA Foundation Research Medal.
Clinicians, patients and other stakeholders in the cancer community are invited to make submissions in support of the PBS listing for pembrolizumab.
The World Congress on Cancers of the Skin 2018 has featured many minds from MIA sharing their expertise and wealth of knowledge with over 1000 attendees from around the world.
Melanoma Institute Australia is delighted to announce the appointment of Matthew Browne as Chief Executive Officer (CEO).
It was a full house this week at Melanoma Institute Australia thanks to our ‘Melanoma in Practice: Nurse Conference’.
A new study from The University of Sydney shows that sunscreen reduces melanoma risk by 40 per cent when used from a young age.
Melanoma Institute Australia (MIA) has launched a free e-learning portal to educate healthcare professionals about the latest advances in melanoma diagnosis and treatment.
When David lost his life last year, he was 33, with three daughters under six.
Clinical trials are just that – trials in a clinical setting to evaluate the effectiveness or otherwise of individual and combination treatments.
Melanoma Institute Australia scooped the award pool at the Annual Scientific Meeting of the International Academy of Pathology.
Melanoma patients across Australia will benefit from the release of updated clinical care guidelines.
An American study has discovered a link between early detection and marital status in melanoma diagnosis.
An international course on melanoma pathology in Paris, France co-directed by Professor Richard Scolyer took place over the weekend.
Professor Richard Scolyer highlights the difficulties of diagnosis following the Australian Story feature program on Emma Betts.
Cancer Australia releases 'stage at diagnosis' data for top five incidence cancers – including melanoma
For the first time in Australia, national data has been released on cancer stage at diagnosis. This data explores the top five incidence cancers – female breast cancer, colorectal, lung, prostate cancers and melanoma.
'Dear Emma' - a tribute to the life and times of a young woman determined to raise awareness about melanoma.
Carole Renouf, CEO for MIA thanks Toyota for helping fuel ongoing melanoma research.
Fraser Dykes tackled the Kokoda Trail on an eight day trek in memory of his friend Mark 'Bod' Boddison.
Harvard’s Clinical Professor Martin Mihm and MIA’s Conjoint Medical Director Professor Richard Scoyler delivered a series of lectures on melanoma pathology in Vancouver, British Colombia this week at the world’s biggest annual pathology meeting.